Boehringer Ingelheim at ASCO 2027
Jun 4–8, 2027 Chicago, IL ~44k attendees Website
Boehringer Ingelheim at ASCO 2027 in Chicago: Booth 27109.
| Organization | ASCO 2027 Attendance |
|---|---|
Boehringer Ingelheim Ingelheim, Germany | |
Family-owned German drugmaker whose oncology work centers on lung cancer, including the HER2 inhibitor zongertinib, plus other solid tumors. | Booth Exhibiting at Booth 27109 |
Instantly find 20 buyers from Boehringer Ingelheim
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with the American Society of Clinical Oncology. Organization details are derived from ASCO’s published exhibitor list and each exhibitor’s own profile and website. Submit a correction